ChiCTR2500108866 版本V1.0 版本创建时间2025/09/08 14:26:26 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2500108866 

最近更新日期:

Date of Last Refreshed on:

2025-09-08 14:26:06 

注册时间:

Date of Registration:

2025-09-08 00:00:00 

注册号状态:

补注册

Registration Status:

Retrospective registration

注册题目:

重症恙虫病并发胰腺炎相关性腹腔积液:病例报告

Public title:

Case report of severe scrub typhus complicated with pancreatitis-associated ascitic fluid

注册题目简写:

English Acronym:

研究课题的正式科学名称:

Case report of severe scrub typhus complicated with pancreatitis-associated ascitic fluid

Scientific title:

Case report of severe scrub typhus complicated with pancreatitis-associated ascitic fluid

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

孙嫣 

研究负责人:

孙嫣 

Applicant:

Sun Yan 

Study leader:

Sun Yan 

申请注册联系人电话:

Applicant telephone:

+86 13711468619

研究负责人电话:

Study leader's telephone:

+86 13711468619

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

2010683015@gzhmu.edu.cn

研究负责人电子邮件:

Study leader's E-mail:

hilary1107@126.com

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

广东省广州市荔湾区多宝路63号

研究负责人通讯地址:

广东省广州市荔湾区多宝路63号

Applicant address:

No. 63, Duobao Road, Liwan District, Guangzhou City, Guangdong Province

Study leader's address:

No. 63, Duobao Road, Liwan District, Guangzhou City, Guangdong Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

广州医科大学附属第三医院

Applicant's institution:

The Third Affiliated Hospital of Guangzhou Medical University

研究负责人所在单位:

广州医科大学附属第三医院

Affiliation of the Leader:

The Third Affiliated Hospital of Guangzhou Medical University

是否获伦理委员会批准:

是/Yes

Approved by ethic committee:

Yes

伦理委员会批件文号:

Approved No. of ethic committee:

医伦会审[2024]第 118 号

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件View

批准本研究的伦理委员会名称:

广州医科大学附属第三医院伦理委员会

Name of the ethic committee:

Ethics Committee of the Third Affiliated Hospital of Guangzhou Medical University

伦理委员会批准日期:

Date of approved by ethic committee:

2024-07-23 00:00:00

伦理委员会联系人:

龙土红

Contact Name of the ethic committee:

Long Tuhong

伦理委员会联系地址:

广东省广州市荔湾区多宝路63号

Contact Address of the ethic committee:

No. 63, Duobao Road, Liwan District, Guangzhou City, Guangdong Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

+86 20 81292726

伦理委员会联系人邮箱:

Contact email of the ethic committee:

1269918380@qq.com

研究实施负责(组长)单位:

广州医科大学附属第三医院

Primary sponsor:

The Third Affiliated Hospital of Guangzhou Medical University

研究实施负责(组长)单位地址:

广东省广州市荔湾区多宝路63号

Primary sponsor's address:

No. 63, Duobao Road, Liwan District, Guangzhou City, Guangdong Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东

市(区县):

Country:

China

Province:

Guangdong

City:

单位(医院):

广州医科大学附属第三医院

具体地址:

广东省广州市荔湾区多宝路63号

Institution
hospital:

The Third Affiliated Hospital of Guangzhou Medical University

Address:

No. 63, Duobao Road, Liwan District, Guangzhou City, Guangdong Province

经费或物资来源:

Source(s) of funding:

None

Target disease:

Scrub typhus-associated acute severe pancreatitis; Pancreatic fistula; Pancreatic peritoneal effusion; Pancreatic pseudocyst

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

病例研究 

Study design:

Case study 

研究目的:

该研究是为了说明感染恙虫病后的一种罕见的并发症。  

Objectives of Study:

The study was conducted to illustrate a rare complication of infection with tsutsugamushi disease.

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

1.感染恙虫病后进展为胰腺炎相关性腹水的患者; 2.受试者来源于广州医科大 学附属第三医院; 3.患者为男性; 4.年龄为65岁。

Inclusion criteria

1.Patients who progress to pancreatitis-associated ascites after being infected with scrub typhus; 2.The subjects were from the Third Affiliated Hospital of Guangzhou Medical University; 3.The patient is male. 4.The age is 65.

排除标准:

Exclusion criteria:

None

研究实施时间:

Study execute time:

From 2023-09-01 00:00:00 To 2024-06-30 00:00:00  

征募观察对象时间:

Recruiting time:

From 2024-06-25 00:00:00 To 2024-06-30 00:00:00  

干预措施:

Interventions:

组别:

研究组

样本量:

1

Group:

Research Group

Sample size:

干预措施:

干预措施代码:

Intervention:

None

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

广东 

市(区县):

 

Country:

China 

Province:

Guangdong 

City:

 

单位(医院):

广州医科大学附属第三医院 

单位级别:

三级甲等 

Institution
hospital:

The Third Affiliated Hospital of Guangzhou Medical University

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

血清淀粉酶

指标类型:

主要指标

Outcome:

Serum amylase

Type:

Primary indicator

测量时间点:

治疗期间间隔1-3天复查1次

测量方法:

Measure time point of outcome:

Every 1-3 days during treatment

Measure method:

指标中文名:

腹水淀粉酶

指标类型:

主要指标

Outcome:

Ascites amylase

Type:

Primary indicator

测量时间点:

治疗期间间隔1-3天复查1次

测量方法:

Measure time point of outcome:

Every 1-3 days during treatment

Measure method:

指标中文名:

血清白蛋白

指标类型:

次要指标

Outcome:

Serum albumin

Type:

Secondary indicator

测量时间点:

入院时、症状缓解后

测量方法:

Measure time point of outcome:

At admission and after symptoms relief

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

血液

组织:

Sample Name:

Blood

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

标本中文名:

腹水

组织:

Sample Name:

Ascites

Tissue:

人体标本去向

使用后销毁  

说明

Fate of sample:

Destruction after use  

Note:

征募研究对象情况:

Recruiting status:

结束

/Completed

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男性

Gender:

Male

随机方法(请说明由何人用什么方法产生随机序列):

Randomization Procedure (please state who generates the random number sequence and by what method):

None

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

不公开/Private

盲法:

Blinding:

None

是否共享原始数据:

IPD sharing

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

邮件联系研究者

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Email contact with the researcher

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

None

数据与安全监察委员会:

Data and Safety Monitoring Committee:

无/No

注册人:

Name of Registration:

 2025-09-08 14:26:06